 |
|
|
| |
TAF in Women/WAVES Global Women's Study - The Efficacy and Safety of Elvitegravir/Cobicistat/
Emtricitabine/Tenofovir Disoproxil Fumarate and
Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir
Disoproxil Fumarate in Treatment-Naïve Women With HIV-1 Infection:
Week 48 Analysis of the Phase 3, Randomized, Double-blind Study
|
| |
| |
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
Cissy Kityo,1 Kathleen Squires,2 Margaret Johnson,3 Teresa Branco,4 Frank Post,5 Oleg Kozyrev,6 Debbie Hagins,7 Anchalee Avihingsanon,8 Shuping Jiang,9 Kirsten White,9 Andrew Cheng,9 Javier Szwarcberg,9 Huyen Cao,9 WAVES Study Group
1Joint Clinical Research Centre, Kampala, Uganda; 2Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA; 3Royal Free Hospital, London, UK; 4Hospital Prof Doutor Fernando Fonseca, EPE, Amadora, Portugal; 5Kings College London, UK; 6Volgograd Center of AIDS, Volgograd, Russian Federation; 7Chatham County Health Department, Savannah, Georgia, USA; 8The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 9Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
